Updates are available Correction dated 2024-06-23
Click to view Correction: https://doi.org/10.1245/s10434-024-15641-x
-
Authors
Lwin, Thinzar M.
Kaelberer, Zoey
Ruan, Mengyuan
Molina, George
Boland, Genevieve
- License Information
-
More Information
Article History
Received: 17 January 2023
Accepted: 16 March 2023
First Online: 1 May 2023
Change Date: 23 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-024-15641-x
Disclosures
: Genevieve M. Boland has sponsored research agreements through her institution with Olink Proteomics, Teiko Bio, InterVenn Biosciences, Palleon Pharmaceuticals. She served on advisory boards for Iovance, Merck, Nektar Therapeutics, Novartis, and Ankyra Therapeutics. She consults for: Merck, InterVenn Biosciences, and Ankyra Therapeutics. She holds equity in Ankyra Therapeutics. The remaining authors have no conflicts of interest.
